C025DZZ
Tomographic (Tomo) Nuclear Medicine Imaging Cerebrospinal Fluid to None with None, Indium 111 (In-111) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | 0 Central Nervous System |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | 5 Cerebrospinal Fluid |
| Approach | D Indium 111 (In-111) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
Tomographic nuclear medicine imaging of the central nervous system, commonly known as brain SPECT (single photon emission computed tomography), involves injecting a small amount of a radioactive tracer into the bloodstream and then rotating a camera around the head to build a three-dimensional picture of blood flow or metabolic activity inside the brain. Because the tracer distributes according to how much blood or activity is reaching different regions, the resulting images can reveal areas that are underperforming even when a standard CT or MRI looks structurally normal.
Physicians order these scans to evaluate seizure disorders (identifying the region where seizures originate), to assess suspected dementia when the type is unclear, to investigate blood flow after a stroke, and occasionally to help confirm brain death. The scan itself is painless; the tracer is given by injection and the imaging table simply rotates a detector around the patient over roughly 20-40 minutes.
Anatomy & Axis Detail
Cerebrospinal Fluid
Tomographic imaging of cerebrospinal fluid combines the flow-tracking principle of radionuclide cisternography with SPECT's cross-sectional reconstruction, allowing better localization of CSF leak sites or flow obstructions than planar images alone can provide, particularly when the site of interest lies close to the skull base or spine where overlapping structures on a flat image would obscure findings. This is used selectively, generally when planar images are equivocal or when precise anatomic localization is needed before a surgical repair of a dural defect. As with planar CSF studies, the imaging timeline is dictated by the slow physiologic movement of cerebrospinal fluid rather than by tracer clearance kinetics typical of other tomographic exams, so delayed-phase SPECT acquisitions are common.
Radionuclide: Indium 111 (In-111)
Indium 111 (In-111) designates studies using this radionuclide, commonly bound to white blood cells or specific peptides for infection imaging, tumor localization, or cerebrospinal fluid flow studies. It has a longer half-life than Technetium 99m, making it suited to delayed imaging over days. This value distinguishes such studies from those using shorter-lived isotopes like Tc-99m or positron-emitting tracers such as Fluorine 18.
Coding & Documentation
A code from this family is assigned when documentation confirms a rotational (tomographic) acquisition rather than a single flat image, and specifies the radioactive tracer administered, since the qualifier reflects the substance used (e.g., technetium-99m HMPAO for perfusion studies). Supporting documentation should name the tracer, confirm the SPECT technique, and identify the CNS structure imaged.
The most frequent assignment errors are confusing this root operation with PET imaging when the report only says "nuclear brain scan" without stating the modality, and defaulting to a planar imaging code when the physician actually performed a rotational SPECT acquisition. Coders should also avoid assuming a tracer from the clinical indication alone; the radiopharmaceutical must be explicitly documented.